Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Airway epithelial ion transport is a coordinated physiological process responsible for maintaining the volume, composition, and pH of the airway surface liquid (ASL), which is essential for effective mucociliary clearance and lung defense [2, 5, 14]. This system involves a variety of ion channels and transporters, most notably the cystic fibrosis transmembrane conductance regulator (CFTR) for chloride and bicarbonate secretion, and the epithelial sodium channel (ENaC) for sodium absorption [7, 14, 16]. In diseases like cystic fibrosis, mutations in CFTR lead to defective anion secretion and unregulated sodium hyperabsorption, resulting in ASL dehydration, thick mucus, and chronic infection [7, 13, 16]. Therapeutic strategies target this system through CFTR modulators, such as potentiators and correctors, to restore channel function, or ENaC inhibitors to prevent excessive fluid absorption [10, 11, 15]. Other components like TMEM16A and SLC26A9 are also being explored as alternative targets to bypass CFTR defects and rehydrate the airways [9, 11, 15]. Proper regulation of these transport mechanisms is vital for preventing the progression of chronic obstructive pulmonary disease (COPD) and other respiratory conditions [3, 13].
Modulation of airway epithelial ion transport involves CFTR potentiation and correction to restore chloride and bicarbonate secretion [11, 15], ENaC inhibition to block excessive sodium and water reabsorption [8, 15], activation of purinergic receptors (e.g., P2Y2) to stimulate alternative chloride channels [12], or the use of osmotic agents to directly hydrate the airway surface liquid [11].
10 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Airway epithelial ion transport.